- Home
- ARVN vs LILA Comparison
ARVN vs LILA Comparison
Compare ARVN & LILA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- LILA
- Stock Information
- Founded
- ARVN 2015
- LILA 2017
- Country
- ARVN United States
- LILA Bermuda
- Employees
- ARVN N/A
- LILA N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- LILA Cable & Other Pay Television Services
- Sector
- ARVN Health Care
- LILA Telecommunications
- Exchange
- ARVN Nasdaq
- LILA Nasdaq
- Market Cap
- ARVN 1.7B
- LILA 1.8B
- IPO Year
- ARVN 2018
- LILA N/A
- Fundamental
- Price
- ARVN $25.76
- LILA $9.72
- Analyst Decision
- ARVN Strong Buy
- LILA Buy
- Analyst Count
- ARVN 15
- LILA 2
- Target Price
- ARVN $57.50
- LILA $8.65
- AVG Volume (30 Days)
- ARVN 487.9K
- LILA 238.2K
- Earning Date
- ARVN 10-30-2024
- LILA 11-07-2024
- Dividend Yield
- ARVN N/A
- LILA N/A
- EPS Growth
- ARVN N/A
- LILA N/A
- EPS
- ARVN N/A
- LILA N/A
- Revenue
- ARVN $93,300,000.00
- LILA $4,506,800,000.00
- Revenue This Year
- ARVN $179.49
- LILA $2.30
- Revenue Next Year
- ARVN N/A
- LILA $3.66
- P/E Ratio
- ARVN N/A
- LILA N/A
- Revenue Growth
- ARVN N/A
- LILA N/A
- 52 Week Low
- ARVN $13.57
- LILA $5.90
- 52 Week High
- ARVN $53.08
- LILA $10.82
- Technical
- Relative Strength Index (RSI)
- ARVN 50.68
- LILA 51.05
- Support Level
- ARVN $25.42
- LILA $9.51
- Resistance Level
- ARVN $29.24
- LILA $10.17
- Average True Range (ATR)
- ARVN 1.24
- LILA 0.25
- MACD
- ARVN 0.18
- LILA 0.03
- Stochastic Oscillator
- ARVN 34.71
- LILA 46.75
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About LILA Liberty Latin America Ltd.
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico, and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.